TransThera Sciences (Nanjing), Inc. (02617) Announces Monthly Return on Movements in Securities for November 2025

Bulletin Express12-02

TransThera Sciences (Nanjing), Inc. (02617) published its Monthly Return on Movements in Securities for the period ended 30 November 2025. According to the announcement, the company's authorized share capital remained RMB 396,897,633, comprising 301,666,673 H shares and 95,230,960 unlisted shares, each with a par value of RMB 1. No changes were reported in either category during the month.

The total number of issued H shares remained at 301,666,673, while unlisted shares stood at 95,230,960. No share issuances, cancellations, or share repurchases were recorded. The announcement was submitted on 02 December 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment